228 related articles for article (PubMed ID: 19913192)
1. Stress-related neuropeptides and alcoholism: CRH, NPY, and beyond.
Ciccocioppo R; Gehlert DR; Ryabinin A; Kaur S; Cippitelli A; Thorsell A; Lê AD; Hipskind PA; Hamdouchi C; Lu J; Hembre EJ; Cramer J; Song M; McKinzie D; Morin M; Economidou D; Stopponi S; Cannella N; Braconi S; Kallupi M; de Guglielmo G; Massi M; George DT; Gilman J; Hersh J; Tauscher JT; Hunt SP; Hommer D; Heilig M
Alcohol; 2009 Nov; 43(7):491-8. PubMed ID: 19913192
[TBL] [Abstract][Full Text] [Related]
2. Neurobiological mechanisms contributing to alcohol-stress-anxiety interactions.
Silberman Y; Bajo M; Chappell AM; Christian DT; Cruz M; Diaz MR; Kash T; Lack AK; Messing RO; Siggins GR; Winder D; Roberto M; McCool BA; Weiner JL
Alcohol; 2009 Nov; 43(7):509-19. PubMed ID: 19913194
[TBL] [Abstract][Full Text] [Related]
3. Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism.
Lowery EG; Thiele TE
CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):77-86. PubMed ID: 20201818
[TBL] [Abstract][Full Text] [Related]
4. Alcoholism and neuropeptides: an update.
Cowen MS; Lawrence AJ
CNS Neurol Disord Drug Targets; 2006 Apr; 5(2):233-9. PubMed ID: 16611096
[TBL] [Abstract][Full Text] [Related]
5. Young Investigator Award symposium.
Witkiewitz K; Holmes A; Ray LA; Murphy JG; Richardson HN; Chen YC; McDevitt-Murphy ME; Cruz MT; Roberto M
Alcohol; 2009 Nov; 43(7):499-508. PubMed ID: 19913193
[TBL] [Abstract][Full Text] [Related]
6. Targeting NPY, CRF/UCNs and NPS Neuropeptide Systems to Treat Alcohol Use Disorder (AUD).
Rodriguez FD; Coveñas R
Curr Med Chem; 2017; 24(23):2528-2558. PubMed ID: 28302012
[TBL] [Abstract][Full Text] [Related]
7. Treatment of alcohol dependence with drug antagonists of the stress response.
Higley AE; Koob GF; Mason BJ
Alcohol Res; 2012; 34(4):516-21. PubMed ID: 23584117
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of Nociceptin/Orphanin FQ and Dynorphin Systems in the Extended Amygdala of Alcohol Preferring Marchigian Sardinian (msP) Rats.
Caputi FF; Stopponi S; Rullo L; Palmisano M; Ubaldi M; Candeletti S; Ciccocioppo R; Romualdi P
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671048
[TBL] [Abstract][Full Text] [Related]
9. The central amygdala and alcohol: role of γ-aminobutyric acid, glutamate, and neuropeptides.
Roberto M; Gilpin NW; Siggins GR
Cold Spring Harb Perspect Med; 2012 Dec; 2(12):a012195. PubMed ID: 23085848
[TBL] [Abstract][Full Text] [Related]
10. Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH.
Weninger SC; Dunn AJ; Muglia LJ; Dikkes P; Miczek KA; Swiergiel AH; Berridge CW; Majzoub JA
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8283-8. PubMed ID: 10393986
[TBL] [Abstract][Full Text] [Related]
11. Functional antagonism between nociceptin/orphanin FQ and corticotropin-releasing factor in rat anxiety-related behaviors: involvement of the serotonergic system.
Filaferro M; Ruggieri V; Novi C; Calò G; Cifani C; Micioni Di Bonaventura MV; Sandrini M; Vitale G
Neuropeptides; 2014 Aug; 48(4):189-97. PubMed ID: 24894718
[TBL] [Abstract][Full Text] [Related]
12. Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence.
Walker BM; Valdez GR; McLaughlin JP; Bakalkin G
Alcohol; 2012 Jun; 46(4):359-70. PubMed ID: 22459870
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.
Heilig M; Egli M
Pharmacol Ther; 2006 Sep; 111(3):855-76. PubMed ID: 16545872
[TBL] [Abstract][Full Text] [Related]
14. Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin.
Martin-Fardon R; Zorrilla EP; Ciccocioppo R; Weiss F
Brain Res; 2010 Feb; 1314():145-61. PubMed ID: 20026088
[TBL] [Abstract][Full Text] [Related]
15. Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety.
Thorsell A
Exp Biol Med (Maywood); 2010 Oct; 235(10):1163-7. PubMed ID: 20881320
[TBL] [Abstract][Full Text] [Related]
16. The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat.
Sajdyk TJ; Fitz SD; Shekhar A
Stress; 2006 Mar; 9(1):21-8. PubMed ID: 16753930
[TBL] [Abstract][Full Text] [Related]
17. Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues.
Heilig M; Thorsell A; Sommer WH; Hansson AC; Ramchandani VA; George DT; Hommer D; Barr CS
Neurosci Biobehav Rev; 2010 Nov; 35(2):334-44. PubMed ID: 19941895
[TBL] [Abstract][Full Text] [Related]
18. Region-specific roles of the corticotropin-releasing factor-urocortin system in stress.
Henckens MJ; Deussing JM; Chen A
Nat Rev Neurosci; 2016 Oct; 17(10):636-51. PubMed ID: 27586075
[TBL] [Abstract][Full Text] [Related]
19. The corticotropin-releasing factor/urocortin system and alcohol.
Ryabinin AE; Bachtell RK; Heinrichs SC; Lee S; Rivier C; Olive MF; Mehmert KK; Camarini R; Kim JA; Koenig HN; Nannini MA; Hodge CW; Roberts AJ; Koob GF
Alcohol Clin Exp Res; 2002 May; 26(5):714-22. PubMed ID: 12045481
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of serotonin outflow by nociceptin/orphaninFQ in dorsal raphe nucleus slices from normal and stressed rats: Role of corticotropin releasing factor.
Nazzaro C; Marino S; Barbieri M; Siniscalchi A
Neurochem Int; 2009; 54(5-6):378-84. PubMed ID: 19418633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
